Profil

Schmitz Sebastian

See author's contact details
Main Referenced Co-authors
Andraos-Rey, Rita (1)
Bürstner, Nathalie (1)
Büttner, Reinhard (1)
Chariot, Alain  (1)
Charloteaux, Benoit  (1)
Main Referenced Keywords
Cancer (1); Degron Knock-In (1); MDS (1); Melanoma (1); Spliceosomal Mutations (1);
Main Referenced Unit & Research Centers
GIGA Molecular Biology of Diseases - ULiège [BE] (1)
Novartis Institute of Biomedical Research (NIBR) (1)
Main Referenced Disciplines
Oncology (1)
Biochemistry, biophysics & molecular biology (1)

Publications (total 2)

The most downloaded
18 downloads
Rapino, F., Delaunay, S., Rambow, F., Zhou, Z., Tharun, L., De Tullio, P., Sin, O., Shostak, K., Schmitz, S., Piepers, J., Guesquière, B., Karim, L., Charloteaux, B., Jamart, D., Florin, A., Lambert, C., RORIVE, A., JERUSALEM, G., Leucci, E., ... Close, P. (28 June 2018). Codon-specific translation reprogramming promotes resistance to targeted therapy. Nature, 558, 605-609. doi:10.1038/s41586-018-0243-7 https://hdl.handle.net/2268/225765

The most cited

155 citations (Scopus®)

Rapino, F., Delaunay, S., Rambow, F., Zhou, Z., Tharun, L., De Tullio, P., Sin, O., Shostak, K., Schmitz, S., Piepers, J., Guesquière, B., Karim, L., Charloteaux, B., Jamart, D., Florin, A., Lambert, C., RORIVE, A., JERUSALEM, G., Leucci, E., ... Close, P. (28 June 2018). Codon-specific translation reprogramming promotes resistance to targeted therapy. Nature, 558, 605-609. doi:10.1038/s41586-018-0243-7 https://hdl.handle.net/2268/225765

Rapino, F., Delaunay, S., Rambow, F., Zhou, Z., Tharun, L., De Tullio, P., Sin, O., Shostak, K., Schmitz, S., Piepers, J., Guesquière, B., Karim, L., Charloteaux, B., Jamart, D., Florin, A., Lambert, C., RORIVE, A., JERUSALEM, G., Leucci, E., ... Close, P. (28 June 2018). Codon-specific translation reprogramming promotes resistance to targeted therapy. Nature, 558, 605-609. doi:10.1038/s41586-018-0243-7
Peer Reviewed verified by ORBi

Schmitz, S., Bürstner, N., Andraos-Rey, R., & Radimerski, T. (21 June 2016). Identification and characterization of preclinical models of spliceosome mutant myelodysplastic syndromes [Poster presentation]. Mosa Conference `It's all in our blood`, Maastricht, Netherlands.

Contact ORBi